Estrogen Treatment in Acromegalic Women

• Status: Unknown status
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Université de Montréal
• Collaborator: Novartis

Criteria

Inclusion Criteria:

• Women 18 years and older treated with somatostatin analogs

• Active acromegaly

Exclusion Criteria:

• Cardiovascular or cerebrovascular disease

• Thrombophlebitis or thromboembolism

• Breast cancer

• Non-controlled arterial hypertension

• Smoking

• Pregnancy or lactation